fbpx

Mindfulness training may boost cognitive and emotional wellbeing

Mindfulness training may boost cognitive and emotional wellbeing Published: 28 July 2020 Just four weeks of mindfulness meditation could help to improve emotional balance and thinking ability in people with multiple sclerosis (MS), and even more so than cognitive training, new research had found.  The study split 61 patients randomly
Read More

Change in advice for those shielding

Change in advice for those shielding Published: 24 June 2020 Vulnerable and at-risk groups, including some people with multiple sclerosis (MS) will soon be able to spend time outside their homes, the Health and Social Care Secretary has announced.  From Monday 6 July, people shielding from COVID-19 will be able
Read More

Switching from Tysabri increases risk of relapse

Switching from Tysabri increases risk of relapse Published: 18 June 2020 A new study has found the risk of a relapse for someone with relapsing remitting multiple sclerosis (RRMS) switching from Tysabri (natalizumab) to another injectable or oral after two or more years on the therapy is two to three
Read More

MS increases vascular mortality risk

MS increases vascular mortality risk Published: 28 May 2020 New research has found that having multiple sclerosis (MS) is associated with an increased risk of acute coronary syndrome (ACS), stroke, and death, and the findings cannot be explained by traditional risk factors.  Scientists found that participants with MS had a
Read More

Long-term fingolimod treatment may lessen disability

Long-term fingolimod treatment may lessen disability Published: 27 May 2020 Long-term treatment with fingolimod results in lesser disability in people with relapsing remitting multiple sclerosis (MS), a new study has found.  People treated with the drug for eight or more years had smaller increases in disability over the course of
Read More

Spasticity scale test not enough to show Sativex benefits

Spasticity scale test not enough to show Sativex benefits Published: 26 May 2020 A new study from Italy has found that Sativex, a type of medical cannabis licensed in the UK for some symptoms of multiple sclerosis MS, eases symptoms related to spasticity, even in those with no significant improvements
Read More

Obesity linked to faster optic nerve degeneration

Obesity linked to faster optic nerve degeneration Published: 07 May 2020 Being obese is linked to a faster degeneration of optic nerve tissue in people with multiple sclerosis (MS) than in those of a normal body weight, a new study has found.  Researchers at Johns Hopkins University, who conducted the
Read More

New technique to detect early-stage MS

New technique to detect early-stage MSPublished: 30 April 2020 Scientists have developed a new technique to diagnose early-stage multiple sclerosis (MS) and distinguish it from a similar autoimmune condition called neuromyelitis optica.  Brazilian researchers used a nanobiosensor, which was originally created to detect pollutants like herbicides and heavy metals, and
Read More

New subset of monocytes offers hope for MS treatment

New subset of monocytes offers hope for MS treatment Published: 29 April 2020 A new mouse model study has suggested targeting a subset of monocytes, a type of immune cell, might be a better way to treat multiple sclerosis (MS) than targeting all of the immune system’s cells, which is
Read More